Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
$0.40
$0.56
$0.20
$6.97
$2.74M1.42119,114 shs28,123 shs
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
$0.22
+4.9%
$0.31
$0.19
$2.98
$2.29M2.67193,343 shs109,097 shs
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
$0.30
-6.2%
$0.37
$0.27
$2.70
$4.48M0.91467,499 shs233,061 shs
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$0.75
+2.7%
$1.01
$0.71
$23.00
$2.80M2.2426,302 shs28,678 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
0.00%+5.26%+17.65%-74.68%-93.94%
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
-1.38%+6.44%-40.61%-48.77%-87.35%
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
0.00%-4.82%-18.56%-35.41%-82.22%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
0.00%+2.52%-20.89%-40.73%-61.46%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
2.4479 of 5 stars
3.32.00.04.00.00.00.0
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
2.0231 of 5 stars
3.55.00.00.02.20.00.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
2.50
Moderate Buy$8.502,025.00% Upside
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/AN/AN/AN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
3.00
Buy$3.00299.17% Upside

Current Analyst Ratings

Latest CPHI, AGRX, CNSP, and TNON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSpeculative Buy ➝ Speculative Buy$5.00 ➝ $3.00
3/18/2024
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
$19.59M0.14N/AN/A($5.51) per share-0.07
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/AN/AN/AN/A($0.71) per shareN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
$7.01M0.64N/AN/A$0.70 per share0.43
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$2.93M0.96N/AN/A$0.30 per share2.51

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
-$14.47M-$9.84N/AN/A-73.83%N/A-179.07%5/9/2024 (Estimated)
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
-$18.85M-$5.66N/AN/AN/A-603.40%-421.35%5/20/2024 (Estimated)
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
-$3.08MN/A0.00N/A-43.91%-54.53%-18.98%N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$15.58M-$9.74N/AN/A-532.14%-934.11%-200.10%5/14/2024 (Estimated)

Latest CPHI, AGRX, CNSP, and TNON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/A-$0.95-$0.95-$0.95N/AN/A
3/28/2024Q4 2023
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
N/A-$1.46-$1.46-$1.41N/A$3.62 million
3/12/2024Q4 2023
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/A-$0.68-$0.68-$0.68N/A$0.81 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
N/AN/AN/AN/AN/A
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/AN/AN/AN/AN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
N/A
0.46
0.33
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
N/A
0.26
0.26
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
0.19
0.88
0.33
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/A
1.24
1.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
10.92%
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
14.02%
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
22.74%

Insider Ownership

CompanyInsider Ownership
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
0.50%
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
3.88%
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
46.00%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
8.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agile Therapeutics, Inc. stock logo
AGRX
Agile Therapeutics
196.86 million6.82 millionNot Optionable
CNS Pharmaceuticals, Inc. stock logo
CNSP
CNS Pharmaceuticals
310.64 million10.22 millionNot Optionable
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
23114.82 million8.00 millionNot Optionable
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
213.73 million3.41 millionNot Optionable

CPHI, AGRX, CNSP, and TNON Headlines

SourceHeadline
Tenon Medical, Inc.: Tenon Medical Appoints Kristine Jacques to its Board of DirectorsTenon Medical, Inc.: Tenon Medical Appoints Kristine Jacques to its Board of Directors
finanznachrichten.de - March 28 at 8:46 AM
Tenon(R) Medical Appoints Kristine Jacques to its Board of DirectorsTenon(R) Medical Appoints Kristine Jacques to its Board of Directors
accesswire.com - March 28 at 8:00 AM
Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion SystemTenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System
finance.yahoo.com - March 27 at 12:31 AM
Tenon Medical, Inc (TNON) Q4 2023 Earnings Call TranscriptTenon Medical, Inc (TNON) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 14 at 2:59 PM
Buy Rating Affirmed for Tenon Medical on Strong Market Penetration and Strategic Growth InitiativesBuy Rating Affirmed for Tenon Medical on Strong Market Penetration and Strategic Growth Initiatives
markets.businessinsider.com - March 14 at 2:59 PM
Healthcare Stock Bid Up Before Opening BellHealthcare Stock Bid Up Before Opening Bell
theglobeandmail.com - March 13 at 2:01 PM
Tenon Medical, Inc. (NASDAQ:TNON) Q4 2023 Earnings Call TranscriptTenon Medical, Inc. (NASDAQ:TNON) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 13 at 2:01 PM
Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving PremarketWhy SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
benzinga.com - March 13 at 9:00 AM
Q4 2023 Tenon Medical Inc Earnings CallQ4 2023 Tenon Medical Inc Earnings Call
finance.yahoo.com - March 13 at 9:00 AM
Tenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsTenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
finanznachrichten.de - March 12 at 7:44 PM
Recap: Tenon Medical Q4 EarningsRecap: Tenon Medical Q4 Earnings
benzinga.com - March 12 at 7:44 PM
Tenon Medical GAAP EPS of -$8.59 beats by $1.13, revenue of $2.93M misses by $0.25MTenon Medical GAAP EPS of -$8.59 beats by $1.13, revenue of $2.93M misses by $0.25M
msn.com - March 12 at 7:44 PM
Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsTenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results
accesswire.com - March 12 at 4:05 PM
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial ResultsTenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
accesswire.com - February 27 at 8:00 AM
Tenon Medical Inc TNONTenon Medical Inc TNON
morningstar.com - February 24 at 2:39 PM
Tenon Medical Stock (NASDAQ:TNON), Short Interest ReportTenon Medical Stock (NASDAQ:TNON), Short Interest Report
benzinga.com - February 22 at 8:11 AM
Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint ImplantTenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant
finance.yahoo.com - February 22 at 8:11 AM
Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint ImplantTenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant
accesswire.com - February 22 at 8:00 AM
Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred StockTenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock
finanznachrichten.de - February 21 at 3:47 PM
CORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred StockCORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock
finance.yahoo.com - February 21 at 3:47 PM
CORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred StockCORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock
accesswire.com - February 21 at 11:05 AM
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred StockTenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
finance.yahoo.com - February 21 at 10:47 AM
Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred StockTenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock
accesswire.com - February 21 at 8:00 AM
Tenon Medical, Inc. Announces Second Adjournment of Special Meeting of StockholdersTenon Medical, Inc. Announces Second Adjournment of Special Meeting of Stockholders
finance.yahoo.com - January 8 at 7:13 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Agile Therapeutics logo

Agile Therapeutics

NASDAQ:AGRX
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
CNS Pharmaceuticals logo

CNS Pharmaceuticals

NASDAQ:CNSP
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.
China Pharma logo

China Pharma

NYSE:CPHI
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. The company also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. The company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.
Tenon Medical logo

Tenon Medical

NASDAQ:TNON
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.